| # | Title | Journal | Year | Citations |
|---|
| 1 | Membrane-Bound IL-21 Promotes Sustained Ex Vivo Proliferation of Human Natural Killer Cells | PLoS ONE | 2012 | 488 |
| 2 | International Society for Cellular Therapy perspective on immune functional assays for mesenchymal stromal cells as potency release criterion for advanced phase clinical trials | Cytotherapy | 2016 | 400 |
| 3 | Phase 3 trial of defibrotide for the treatment of severe veno-occlusive disease and multi-organ failure | Blood | 2016 | 255 |
| 4 | Natural killer cells in antitumour adoptive cell immunotherapy | Nature Reviews Cancer | 2022 | 208 |
| 5 | Next generation natural killer cells for cancer immunotherapy: the promise of genetic engineering | Current Opinion in Immunology | 2018 | 178 |
| 6 | Phase I study of cord blood-derived natural killer cells combined with autologous stem cell transplantation in multiple myeloma | British Journal of Haematology | 2017 | 158 |
| 7 | A new approach to gene therapy using Sleeping Beauty to genetically modify clinical‐grade T cells to target CD19 | Immunological Reviews | 2014 | 121 |
| 8 | The dual PI3 kinase/mTOR inhibitor PI-103 prevents p53 induction by Mdm2 inhibition but enhances p53-mediated mitochondrial apoptosis in p53 wild-type AML | Leukemia | 2008 | 106 |
| 9 | Generation of multi-leukemia antigen-specific T cells to enhance the graft-versus-leukemia effect after allogeneic stem cell transplant | Leukemia | 2013 | 104 |
| 10 | Cord blood natural killer cells expressing a dominant negative TGF-β receptor: Implications for adoptive immunotherapy for glioblastoma | Cytotherapy | 2017 | 97 |
| 11 | The Microbiome and Hematopoietic Cell Transplantation: Past, Present, and Future | Biology of Blood and Marrow Transplantation | 2018 | 85 |
| 12 | Tacrolimus‐associated posterior reversible encephalopathy syndrome in hematopoietic allogeneic stem cell transplantation | American Journal of Hematology | 2013 | 81 |
| 13 | Graft-versus-host disease | Journal of the American Academy of Dermatology | 2012 | 76 |
| 14 | Concise Review: Umbilical Cord Blood Transplantation: Past, Present, and Future | Stem Cells Translational Medicine | 2014 | 75 |
| 15 | ABT‐737 is a useful component of combinatory chemotherapies for chronic myeloid leukaemias with diverse drug‐resistance mechanisms | British Journal of Haematology | 2008 | 71 |
| 16 | Blockade of interleukin‐6 signalling with siltuximab enhances melphalan cytotoxicity in preclinical models of multiple myeloma | British Journal of Haematology | 2011 | 69 |
| 17 | Outcomes of Influenza Infections in Hematopoietic Cell Transplant Recipients: Application of an Immunodeficiency Scoring Index | Biology of Blood and Marrow Transplantation | 2016 | 68 |
| 18 | Apoptosis-based dual molecular targeting by INNO-406, a second-generation Bcr-Abl inhibitor, and ABT-737, an inhibitor of antiapoptotic Bcl-2 proteins, against Bcr-Abl-positive leukemia | Cell Death and Differentiation | 2007 | 64 |
| 19 | Clinical characteristics and outcomes in patients with acute promyelocytic leukaemia and hyperleucocytosis | British Journal of Haematology | 2015 | 64 |
| 20 | Mesenchymal stem cells in ex vivo cord blood expansion | Best Practice and Research in Clinical Haematology | 2011 | 57 |
| 21 | The Effect of Peritransplant Minimal Residual Disease in Adults With Acute Lymphoblastic Leukemia Undergoing Allogeneic Hematopoietic Stem Cell Transplantation | Clinical Lymphoma, Myeloma and Leukemia | 2014 | 55 |
| 22 | Anti-myeloma effect of homoharringtonine with concomitant targeting of the myeloma-promoting molecules, Mcl-1, XIAP, and β-catenin | International Journal of Hematology | 2008 | 53 |
| 23 | Third-party umbilical cord blood–derived regulatory T cells prevent xenogenic graft-versus-host disease | Cytotherapy | 2014 | 53 |
| 24 | Cytogenetics, Donor Type, and Use of Hypomethylating Agents in Myelodysplastic Syndrome with Allogeneic Stem Cell Transplantation | Biology of Blood and Marrow Transplantation | 2014 | 46 |
| 25 | Vorinostat Combined with High-Dose Gemcitabine, Busulfan, and Melphalan with Autologous Stem Cell Transplantation in Patients with Refractory Lymphomas | Biology of Blood and Marrow Transplantation | 2015 | 46 |
| 26 | 5-Aza-2′-deoxycytidine sensitizes busulfan-resistant myeloid leukemia cells by regulating expression of genes involved in cell cycle checkpoint and apoptosis | Leukemia Research | 2010 | 43 |
| 27 | Rituximab for passenger lymphocyte syndrome associated with allogeneic SCT | Bone Marrow Transplantation | 2008 | 41 |
| 28 | Current perspectives on the use of ancillary materials for the manufacture of cellular therapies | Cytotherapy | 2016 | 41 |
| 29 | High-Dose Chemotherapy and Autologous Stem Cell Transplantation for Nodular Lymphocyte-Predominant Hodgkin Lymphoma | Biology of Blood and Marrow Transplantation | 2013 | 36 |
| 30 | Effects of Zinc Supplementation on Antioxidant Status and Lipid Peroxidation in Hemodialysis Patients | | 2013 | 36 |
| 31 | Comparison of Survival in Patients with T Cell Lymphoma after Autologous and Allogeneic Stem Cell Transplantation as a Frontline Strategy or in Relapsed Disease | Biology of Blood and Marrow Transplantation | 2015 | 36 |
| 32 | Human Late Memory CD8+ T Cells Have a Distinct Cytokine Signature Characterized by CC Chemokine Production without IL-2 Production | Journal of Immunology | 2009 | 32 |
| 33 | An overview of conditioning regimens for haploidentical stem cell transplantation with post‐transplantation cyclophosphamide | American Journal of Hematology | 2015 | 31 |
| 34 | Selective FLT3 inhibitor FI-700 neutralizes Mcl-1 and enhances p53-mediated apoptosis in AML cells with activating mutations of FLT3 through Mcl-1/Noxa axis | Leukemia | 2010 | 30 |
| 35 | Haploidentical Hematopoietic Stem Cell Transplantation as a Platform for Post-Transplantation Cellular Therapy | Biology of Blood and Marrow Transplantation | 2015 | 30 |
| 36 | Cathepsin G is broadly expressed in acute myeloid leukemia and is an effective immunotherapeutic target | Leukemia | 2017 | 30 |
| 37 | TRIM44 promotes quiescent multiple myeloma cell occupancy and survival in the osteoblastic niche via HIF-1α stabilization | Leukemia | 2019 | 30 |
| 38 | Adoptive transfer of PR1 cytotoxic T lymphocytes associated with reduced leukemia burden in a mouse acute myeloid leukemia xenograft model | Cytotherapy | 2010 | 27 |
| 39 | Outcome of Patients with Multiple Myeloma and CKS1B Gene Amplification after Autologous Hematopoietic Stem Cell Transplantation | Biology of Blood and Marrow Transplantation | 2016 | 26 |
| 40 | Umbilical cord blood–derived cellular products for cancer immunotherapy | Cytotherapy | 2015 | 22 |
| 41 | Allogeneic transplantation for Hodgkin lymphoma | British Journal of Haematology | 2008 | 20 |
| 42 | Epidermal growth factor receptor is expressed and active in a subset of acute myeloid leukemia | Journal of Hematology and Oncology | 2016 | 20 |
| 43 | De novo T-lymphocyte responses against baculovirus-derived recombinant influenzavirus hemagglutinin generated by a naive umbilical cord blood model of dendritic cell vaccination | Vaccine | 2009 | 19 |
| 44 | Donor clonal hematopoiesis increases risk of acute graft versus host disease after matched sibling transplantation | Leukemia | 2022 | 19 |
| 45 | Inpatient vs outpatient autologous hematopoietic stem cell transplantation for multiple myeloma | European Journal of Haematology | 2017 | 18 |
| 46 | Vaccines as consolidation therapy for myeloid leukemia | Expert Review of Hematology | 2011 | 17 |
| 47 | Improvement in clinical outcome of FLT3 ITD mutated acute myeloid leukemia patients over the last one and a half decade | American Journal of Hematology | 2015 | 17 |
| 48 | Differential properties of human stromal cells from bone marrow, adipose, liver and cardiac tissues | Cytotherapy | 2015 | 15 |
| 49 | Allotransplants for Patients 65 Years or Older with High-Risk Acute Myeloid Leukemia | Biology of Blood and Marrow Transplantation | 2019 | 15 |
| 50 | Tetra-O-methyl nordihydroguaiaretic acid inhibits growth and induces death of leukemia cells independent of Cdc2 and survivin | Leukemia and Lymphoma | 2007 | 12 |
